“…NAD + is a regulator of Sirtuin1 (SIRT1), which has deacetylase activity (Aksoy et al, 2006) in T cells (Jeng et al, 2018), cancer cells (Chatterjee et al, 2018), and adipocytes (Cantó and Auwerx, 2012) because SIRT1 binds NAD + to deacetylate targets (Sauve et al, 2006). One of the molecules, which is deacetylated by SIRT1, is EZH2 (Wan et al, 2015), which modulates epigenetically the expression of several molecules including T-bet, RUNX3, and EOMES by trimethylating histone 3 at lysine 27 (H3K27me3) (Fujii et al, 2008;He et al, 2017;Tong et al, 2014). It has been reported that SIRT1 regulates the activity and stability of EZH2 by acetylating it at lysine 348 in HEK293T cells (Wan et al, 2015).…”